A phase 1b study with selinexor, a first in class selective inhibitor of nuclear export (SINE) in patients with advanced sarcomas: An efficacy analysis Meeting Abstract

  

Authors:	Gounder, M. M.; Zer, A.; Tap, W. D.; Gupta, A. A.; Keohan, M. L.; Dickson, M. A.; D'Angelo, S. P.; Chi, P.; Tanner, L. R.; Konen, T. ; Rashal, T.; McCauley, D.; Saint-Martin, J. R.; Carlson, R.; Marshall, T.; Shacham, S.; Mirza, M. R.; Kauffman, M.; Schwartz, G.; Razak, A. R. A.
Abstract Title:	A phase 1b study with selinexor, a first in class selective inhibitor of nuclear export (SINE) in patients with advanced sarcomas: An efficacy analysis
Meeting Title:	2015 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	33
Issue:	15 Suppl.
Meeting Dates:	2015 May 29-Jun 2
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2015-05-20
Language:	English
ACCESSION:	WOS:000358036900209
PROVIDER:	wos
Notes:	Meeting Abstract: 10569 -- Source: Wos